nach oben

Archives of Women's Mental Health

Erschienen in:

01.02.2011 | Short Communication

Primary care physician’s attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries

verfasst von: Justin L. C. Bilszta, Shauna Tsuchiya, Kwiwon Han, Anne E. Buist, Adrienne Einarson

Erschienen in: Archives of Women's Mental Health | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Little is known about the practices of primary care physicians regarding the prescribing of antidepressants during pregnancy. An anonymous survey was administered to a group of nonrandomly selected Australian general practitioners (n = 61 out of 77) and randomly selected Canadian family physicians (n = 35 out of 111). Responses to a hypothetical scenario and questions regarding beliefs about the use of antidepressant medication during pregnancy were collected. Physicians from both countries feel strongly that antidepressant use during pregnancy is a decision complicated by conflicting reports of safety and risk.

Alwan S, Reefhuis J, Rasmussen S, Olney R, Friedman J, NBDP Study Group (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684–2692CrossRefPubMed

Andrade S, Raebel M, Brown J, Lane K, Livingston J, Boudreau D, Rolnick S, Roblin D, Smith D, Willy M, Staffa J, Platt R (2008) Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198(194):e1–e5PubMed

Andrade S, McPhillips H, Loren D, Raebel M, Lane K, Livingston J, Boudreau D, Smith D, Davis R, Willy M, Platt R (2009) Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 18:246–252CrossRefPubMed

Bakker M, Kölling P, Van Den Berg P, De Walle H, De Jong Van Den Berg L (2008) Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from The Netherlands. Brit J Clin Pharmacol 65:600–606CrossRef

Buist A, Bilszta J, Barnett B, Milgrom J, Condon J, Hayes B, Brooks J (2005) Recognition and management of perinatal depression in general practice: a survey of GPs and postnatal women. Aust Fam Physician 34:787–790PubMed

Buist A, Bilszta J, Milgrom J, Barnett B, Hayes B, Austin M-P (2006) Health professional’s knowledge and awareness of perinatal depression: results of a national survey. Women Birth 19:11–16CrossRefPubMed

Cohen L, Altshuler L, Harlow B, Nonacs R, Newport D, Viguera A, Suri R, Burt V, Hendrick V, Reminick A, Loughead A, Vitonia A, Stowe Z (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. J Am Med Assoc 295:499–507CrossRef

Cooper W, Pont M, Ray W (2007) Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 196:e1–e5

Davis L, Rubanowice D, McPhillips H, Raebel M, Andrade S, Smith D, Ulcickas Yood M, Platt R (2007) Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 16:1086–1094CrossRefPubMed

Einarson T, Einarson A (2005) Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14:823–827CrossRefPubMed

Einarson A, Selby P, Koren G (2001) Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 26:44–48PubMed

Einarson A, Choi J, Einarson T, Koren G (2009) Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 54:242–246PubMed

Freeman M (2007) Antenatal depression: navigating the treatment dilemmas. Am J Psychiatry 164:1162–1165CrossRefPubMed

Kallen B, Olausson P (2007) Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79:301–308CrossRefPubMed

Louik C, Lin A, Werler M, Hernandez-Diaz S, Mitchell A (2007) First trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:2675–2683CrossRefPubMed

Lund N, Pedersen L, Henriksen T (2009) Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 163:949–954CrossRefPubMed

Malm H, Kalukka T, Neuvonen P (2005) Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 106:1289–1296CrossRefPubMed

Moses-Kolko E, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner K (2005) Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. J Am Med Assoc 293:2372–2383CrossRef

Nevin A, Christopher P, Nulman P, Koren G, Einarson A (2002) A survey of physicians knowledge regarding awareness of maternal alcohol use and the diagnosis of FAS. BMC Fam Prac 3:2CrossRef

Pearlstein T (2008) Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci 33:302–318PubMed

Ramos E, St-Andre M, Oraichi D, Berard A (2008) Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 192:344–350CrossRefPubMed

Reis M, Källén B (2010) Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 40:1723–1722CrossRefPubMed

Tsuchiya S, Einarson A (2007) Physicians’ participation in research. Can Med Assoc J 176:18CrossRef

Wichman C, Fothergill A, Moore K, Lang T, Heise R, Watson W (2008) Recent trends in selective serotonin reuptake inhibitor use in pregnancy. J Clin Psychopharmacol 28:714–716CrossRefPubMed

Yonkers K, Wisner K, Stewart D, Oberlander T, Dell D, Stotland N, Ramin S, Chaudron L, Lockwood C (2009) The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 114:703–713CrossRefPubMed

Titel: Primary care physician’s attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries
verfasst von: Justin L. C. Bilszta
Shauna Tsuchiya
Kwiwon Han
Anne E. Buist
Adrienne Einarson
Publikationsdatum: 01.02.2011
Verlag: Springer Vienna
Erschienen in: Archives of Women's Mental Health / Ausgabe 1/2011
Print ISSN: 1434-1816
Elektronische ISSN: 1435-1102
DOI: https://doi.org/10.1007/s00737-010-0197-8

Neu in den Fachgebieten Neurologie und Psychiatrie

25.04.2024 | Hypotonie | Nachrichten

Springer Medizin

Primary care physician’s attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries

Abstract

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2011

Cortisol levels in pregnancy as a psychobiological predictor for birth weight

Letter from the Editors

P.S. Chandra, H. Herrman, J.E. Fisher, M. Kastrup, U. Niaz, M. Rondon, A. Okasha (eds) Contemporary topics in women’s mental health: global perspectives in a changing society

The DSM IV diagnoses of melancholic and atypical depression in pregnancy

The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents

Uneventful use of haloperidol and trihehexyphenidyl during three consecutive pregnancies

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet